Integrating a brief mental health intervention into primary care services for patients with HIV and diabetes in South Africa: study protocol for a trial-based economic evaluation.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
14 05 2019
Historique:
entrez: 17 5 2019
pubmed: 17 5 2019
medline: 23 5 2020
Statut: epublish

Résumé

Depression and alcohol use disorders are international public health priorities for which there is a substantial treatment gap. Brief mental health interventions delivered by lay health workers in primary care services may reduce this gap. There is limited economic evidence assessing the cost-effectiveness of such interventions in low-income and middle-income countries. This paper describes the proposed economic evaluation of a health systems intervention testing the effectiveness, cost-effectiveness and cost-utility of two task-sharing approaches to integrating services for common mental disorders with HIV and diabetes primary care services. This evaluation will be conducted as part of a three-armed cluster randomised controlled trial of clinical effectiveness. Trial clinical outcome measures will include primary outcomes for risk of depression and alcohol use, and secondary outcomes for risk of chronic disease (HIV and diabetes) treatment failure. The cost-effectiveness analysis will evaluate cost per unit change in Alcohol Use Disorder Identification Test and Centre for Epidemiological Studies scale on Depression scores as well as cost per unit change in HIV RNA viral load and haemoglobin A1c, producing results of provider and patient cost per patient year for each study arm and chronic disease. The cost utility analyses will provide results of cost per quality-adjusted life year gained. Additional analyses relevant for implementation including budget impact analyses will be conducted to inform the development of a business case for scaling up the country's investment in mental health services. The Western Cape Department of Health (WCDoH) (WC2016_RP6_9), the South African Medical Research Council (EC 004-2/2015), the University of Cape Town (089/2015) and Oxford University (OxTREC 2-17) provided ethical approval for this study. Results dissemination will include policy briefs, social media, peer-reviewed papers, a policy dialogue workshop and press briefings. PACTR201610001825405.

Identifiants

pubmed: 31092660
pii: bmjopen-2018-026973
doi: 10.1136/bmjopen-2018-026973
pmc: PMC6530312
doi:

Banques de données

PACTR
['PACTR201610001825405']

Types de publication

Clinical Trial Protocol Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e026973

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M014290/1
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Lancet. 2013 Nov 9;382(9904):1575-86
pubmed: 23993280
Health Policy Plan. 2017 Nov 1;32(suppl_4):iv27-iv47
pubmed: 29106512
Soc Sci Med. 2010 Aug;71(3):517-528
pubmed: 20621748
Subst Abuse Treat Prev Policy. 2015 Nov 14;10:46
pubmed: 26576946
PLoS One. 2017 Aug 4;12(8):e0181960
pubmed: 28783739
Eur J Health Econ. 2018 Mar;19(2):173-175
pubmed: 29032482
Hum Resour Health. 2011 Jan 11;9:1
pubmed: 21223546
Lancet. 2018 Oct 27;392(10157):1553-1598
pubmed: 30314863
Arch Gen Psychiatry. 2012 May;69(5):506-14
pubmed: 22566583
J Int AIDS Soc. 2017 Mar 22;20(1):21371
pubmed: 28630651
Med Decis Making. 2007 Mar-Apr;27(2):128-37
pubmed: 17409363
J Stud Alcohol Drugs. 2012 Mar;73(2):226-37
pubmed: 22333330
Soc Sci Med. 2015 Apr;130:42-50
pubmed: 25681713
S Afr Med J. 2011 Sep 28;101(10):751-7
pubmed: 22272856
Value Health. 2009 Mar;12 Suppl 1:S5-9
pubmed: 19250132
Cost Eff Resour Alloc. 2018 Jun 18;16:24
pubmed: 29946229
Psychother Res. 2015;25(4):435-44
pubmed: 24708408
Pharmacoeconomics. 2018 Jan;36(1):79-90
pubmed: 28905279
Health Policy Plan. 2018 Jun 1;33(5):702-706
pubmed: 29596614
Hum Resour Health. 2017 May 26;15(1):35
pubmed: 28549434
Lancet. 2003 Jan 4;361(9351):33-9
pubmed: 12517464
Bull World Health Organ. 2011 Mar 1;89(3):184-94
pubmed: 21379414
Disabil Rehabil. 2004 Jan 21;26(2):103-8
pubmed: 14668147
Pharmacoeconomics. 2018 May;36(5):509-522
pubmed: 29427072
AIDS Res Treat. 2012;2012:751827
pubmed: 22496971
Glob Health Res Policy. 2018 Jun 8;3:17
pubmed: 29930989
Glob Health Action. 2014 May 15;7:23431
pubmed: 24848654
PLoS Med. 2013;10(5):e1001443
pubmed: 23690753
Pharmacoeconomics. 2018 Jul;36(7):745-758
pubmed: 29779120
Soc Psychiatry Psychiatr Epidemiol. 2010 Mar;45(3):393-404
pubmed: 19506789
BMJ. 2013 Aug 19;347:f4913
pubmed: 23959152
AIDS. 2018 Jul 1;32 Suppl 1:S93-S105
pubmed: 29952795
Health Policy Plan. 2010 Mar;25(2):104-11
pubmed: 19917651
Value Health. 2012 Mar-Apr;15(2):249-54
pubmed: 22433755
PLoS One. 2014 Aug 14;9(8):e103754
pubmed: 25121789
J Health Econ. 1996 Oct;15(5):641-53
pubmed: 10164046
Trials. 2018 Mar 16;19(1):185
pubmed: 29548302
Glob Ment Health (Camb). 2017 Jul 31;4:e14
pubmed: 29230310
Health Policy Plan. 2012 Jan;27(1):42-51
pubmed: 21325270
Ann Med. 2001 Jul;33(5):337-43
pubmed: 11491192
Lancet Psychiatry. 2019 Feb;6(2):174-186
pubmed: 30449711
Health Econ. 2010 Oct;19(10):1166-80
pubmed: 19725025
Lancet. 2007 Sep 8;370(9590):851-8
pubmed: 17826170
Value Health. 2013 Sep-Oct;16(6):1091-9
pubmed: 24041360
Health Econ. 2005 May;14(5):487-96
pubmed: 15497198
Eur J Health Econ. 2013 Jun;14(3):367-72
pubmed: 23526140
Diabetes Care. 2008 Jun;31(6):1155-9
pubmed: 18332158
BMJ Open. 2018 Apr 9;8(4):e020539
pubmed: 29632084
Value Health. 2016 Dec;19(8):929-935
pubmed: 27987642
Drug Alcohol Rev. 2010 Nov;29(6):623-30
pubmed: 20973847
Pharmacoeconomics. 2016 May;34(5):447-61
pubmed: 26753558
Value Health. 2014 Jan-Feb;17(1):5-14
pubmed: 24438712
J Health Psychol. 2018 Mar;23(4):618-628
pubmed: 27091759
Diabetes Care. 2002 Mar;25(3):464-70
pubmed: 11874931
Lancet. 2012 Dec 8;380(9858):2029-43
pubmed: 23201214
Psychiatry Res. 2016 Dec 30;246:394-400
pubmed: 27788459
Clin Trials. 2013 Feb;10(1):43-53
pubmed: 23231969
Int J Inj Contr Saf Promot. 2014;21(3):236-43
pubmed: 23837749
J Ment Health Policy Econ. 2008 Sep;11(3):127-33
pubmed: 18806302
Adv Prev Med. 2012;2012:569153
pubmed: 23198159
Psychiatry Res. 2011 Mar 30;186(1):128-32
pubmed: 20843557
Br J Psychiatry. 2008 Feb;192(2):112-7
pubmed: 18245026
Hum Resour Health. 2014 Apr 04;12:18
pubmed: 24708871
Int J Ment Health Syst. 2017 Apr 19;11:31
pubmed: 28428816
Cochrane Database Syst Rev. 2011 Jul 06;(7):CD003318
pubmed: 21735392
BMC Public Health. 2011 Jan 18;11:43
pubmed: 21244656
AIDS Care. 2018 Jan;30(1):103-115
pubmed: 28679283

Auteurs

Vimbayi Mutyambizi-Mafunda (V)

Health Economics Unit, University of Cape Town School of Public Health and Family Medicine, Cape Town, Western Cape, South Africa.

Bronwyn Myers (B)

Alcohol and Drug Abuse Research Unit, South African Medical Research Council, Tygerburg, Western Cape, South Africa.

Katherine Sorsdahl (K)

Department of Psychiatry and Mental Health, Alan J Flisher Centre for Public Mental Health, University of Cape Town, Cape Town, Western Cape, South Africa.

Crick Lund (C)

Department of Psychiatry and Mental Health, Alan J Flisher Centre for Public Mental Health, University of Cape Town, Cape Town, Western Cape, South Africa.
Institute of Psychiatry, Psychology and Neuroscience, Health Services and Population Research, King's College London, London, UK.

Tracey Naledi (T)

Desmond Tutu HIV Research Centre, University of Cape Town School of Public Health and Family Medicine, Observatory, Western Cape, South Africa.
Western Cape Department of Health, Cape Town, Western Cape, South Africa.

Susan Cleary (S)

Health Economics Unit, School of Public Health and Family Medicine, University of Cape Town, Observatory, Western Cape, South Africa.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH